These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8546221)

  • 1. MCF10AT: a model for the evolution of cancer from proliferative breast disease.
    Dawson PJ; Wolman SR; Tait L; Heppner GH; Miller FR
    Am J Pathol; 1996 Jan; 148(1):313-9. PubMed ID: 8546221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenograft model of progressive human proliferative breast disease.
    Miller FR; Soule HD; Tait L; Pauley RJ; Wolman SR; Dawson PJ; Heppner GH
    J Natl Cancer Inst; 1993 Nov; 85(21):1725-32. PubMed ID: 8411256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 6. Benign and malignant proliferative epithelial lesions of the breast; a review.
    Azzopardi JG
    Eur J Cancer Clin Oncol; 1983 Dec; 19(12):1717-20. PubMed ID: 6319145
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 8. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The breast: tissue changes and cancer risk.
    Sinclair RA
    Med J Aust; 1988 Oct; 149(8):424-6. PubMed ID: 3173205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomic markers of human mammary premalignancy and incipient breast cancer.
    Page DL
    Recent Results Cancer Res; 1988; 106():65-72. PubMed ID: 3285417
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct action of estrogen on sequence of progression of human preneoplastic breast disease.
    Shekhar MP; Nangia-Makker P; Wolman SR; Tait L; Heppner GH; Visscher DW
    Am J Pathol; 1998 May; 152(5):1129-32. PubMed ID: 9588879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenograft models of premalignant breast disease.
    Miller FR
    J Mammary Gland Biol Neoplasia; 2000 Oct; 5(4):379-91. PubMed ID: 14973383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pre-invasive tumors and precancerous conditions of the breast: pathologico-anatomic demarcation and clinical consequences].
    Bässler R; Werner J
    Chirurg; 1984 Mar; 55(3):133-41. PubMed ID: 6325099
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
    Shekhar MP; Werdell J; Tait L
    Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of benign proliferative breast disease.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P; Abernathy TG
    Cancer; 1993 Jun; 71(12):3896-907. PubMed ID: 8389654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic mastectomy: pathologic findings in high-risk patients.
    Khurana KK; Loosmann A; Numann PJ; Khan SA
    Arch Pathol Lab Med; 2000 Mar; 124(3):378-81. PubMed ID: 10705389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies.
    Fabris G; Marchetti E; Marzola A; Bagni A; Querzoli P; Nenci I
    J Steroid Biochem; 1987; 27(1-3):171-6. PubMed ID: 3695478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.